ST. PETERSBURG, Fla., April 26 /PRNewswire-FirstCall/ -- Kurt Tarter, President & CEO of Austin MedTech (OTC Pink Sheets: AMTK) /eyeDirecti states: CMP has been a significant contributor to the success of Austin MedTech /eyeDirecti the past 4 years by responding rapidly and accurately in the production of custom ophthalmic packs for our customers. It is strategically in both companies best interest to formalize our relationship through their joining the eyeCentric Group in order to better position both companies for greater future prosperity.
Tim Hutto, President and CEO of CMP (Custom Medical Products) states: I am very pleased to have my company join this forward thinking coalition of companies created by eyeDirecti to deliver a “One-Stop-Shop” single source supply solution to the community of ophthalmology. Since involving my company with eyeDirecti 4 years ago, CMP’s revenues have increased 40% annually with eyeDirecti labeled product now representing 50% of CMP’s total custom sterile trays produced.
eyeCentric Group
A coalition of market leading companies created to deliver a “Single Source Surgical Supply Solution” to the community of ophthalmology and secure multi-year, multi-million dollar surgical supply agreements for its partners.
About Austin CMP, Inc.
CMP is a custom sterile tray (CPT) manufacturer located in Apopka (Suburb of Orlando) Florida, that has been in business since 1997 producing custom products designed to meet the unique requirements of surgeons performing ophthalmic, pain management, bone biopsy and radiology procedures in North America. CMP is in full compliance with FDA & GMP procedures and policies and poised to produce another $10,000,000/yr of custom products in their current facilities with expansion potential to triple this level.
About Austin Medical Technologies, Inc./eyeDirecti(TM) (Brand)
Austin Medical Technologies delivers “DIRECT” from the manufacturer to the Doctor, the only technology based, “Single Source Supply Solution” for custom sterile procedure trays (CPT’s) and medical devices dedicated exclusively to the multi-specialty Ambulatory Surgery Center (ASC) market. Under the brand name eyeDirecti, Austin MedTech is initially focused on Ophthalmology owned and operated ASC’s which consist of 2,500 practices with 15,000 surgeons performing 4.4 million surgical procedures annually at a supply cost of $400,000,000 per year. Visit our e-commerce site at http://www.eyedirecti.com/
The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for forward-looking statements. Certain information included in this communication (as well as information included in oral statements or other written statements made or to be made by Austin Medical Technologies, Inc. or its wholly owned subsidiaries) contains statements that are forward-looking, such as statements relating to the future anticipated direction of the medical and technology industries and plans for future expansion, various business development activities, planned capital expenditures, future funding sources, anticipated sales growth and potential contracts. Such forward-looking information involves important risks and uncertainties that could significantly affect anticipated results in the future and, accordingly, such results may differ from those expressed in any forward-looking statements made by or on behalf of Austin Medical Technologies or its wholly owned subsidiaries. These risks and uncertainties include, but are not limited to, those relating to development and expansion activities, dependence on existing management, financial activities, domestic and global economic conditions, changes in federal or state tax laws, and market competition factors.
Austin Medical Technologies, Inc.
CONTACT: Keith Tarter of Austin Medical Technologies, Inc.,+1-972-370-0197, or investors@austinmedtech.com